peptide corresponding to the human GLUT10 protein (amino acids 367-385).
Biochem/physiol Actions
GLUT10 is a glucose transporter that is encoded by the gene SLC2A10, and is highly expressed in liver and pancreas. Polymorphisms in SLC2A10 may not influence the pathogenesis of type 2 diabetes but the expression of GLUT10 and the interaction with TGF-β signaling pathway has important role in the development of peripheral arterial disease in patients with type 2 diabetes. GLUT10 is also required for the development of cardiovascular system and the notochord in zebrafish embryos.
Physical form
Solution of 1 mg/mL in phosphate buffered saline containing 0.02% sodium azide.
Recent data indicate that loss-of-function mutation in the gene encoding the facilitative glucose transporter GLUT10 (SLC2A10) causes arterial tortuosity syndrome via upregulation of the TGF-β pathway in the arterial wall, a mechanism possibly causing vascular changes in diabetes. We genotyped
The SLC2A10 gene encodes the GLUT10 facilitative glucose transporter, which is expressed in high amounts in liver and pancreas. The gene is mapped to chromosome 20q12-q13.1, a region that has been shown to be linked to type 2 diabetes. The
Human molecular genetics, 21(6), 1248-1259 (2011-11-26)
Growth factor signaling results in dramatic phenotypic changes in cells, which require commensurate alterations in cellular metabolism. Mutations in SLC2A10/GLUT10, a member of the facilitative glucose transporter family, are associated with altered transforming growth factor-β (TGFβ) signaling in patients with
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
